Literature DB >> 8923502

Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats.

S Evangelista1, M Maggi, A R Renzetti.   

Abstract

Neurochemical and functional studies were performed to investigate the role of substance P (SP) during trinitrobenzene sulfonic acid (TNB)-induced colitis. Time course studies showed that tissutal SP-like immunoreactivity levels decreased in acute or chronic phases of the experimental colitis. The affinity of SP was not significantly reduced up to 1 week after TNB-induced colitis but a decreased density of SP binding sites was observed at all times. The subcutaneous administration of neurokinin (NK)1 receptor antagonist RP 67580 (0.1-1 mumol/kg daily x 1 week) did not affect the injury induced by the hapten. These findings suggest that changes in SP seem to be the effect rather than the cause of colitis and differ from those observed in human inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923502     DOI: 10.1016/s0143-4179(96)90004-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  3 in total

1.  The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons.

Authors:  Matthias A Engel; Mohammad Khalil; Sonja M Mueller-Tribbensee; Christoph Becker; Winfried L Neuhuber; Markus F Neurath; Peter W Reeh
Journal:  J Gastroenterol       Date:  2011-11-12       Impact factor: 7.527

2.  Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids.

Authors:  S Bradesi; H Eutamene; J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

3.  Role of perivascular nerve and sensory neurotransmitter dysfunction in inflammatory bowel disease.

Authors:  Charles E Norton; Elizabeth A Grunz-Borgmann; Marcia L Hart; Benjamin W Jones; Craig L Franklin; Erika M Boerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-12       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.